Insider Transactions in Q3 2021 at Vanda Pharmaceuticals Inc. (VNDA)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 15
2021
|
Aranthan Jones Ii Chief Corp. Affairs Officer |
SELL
Open market or private sale
|
Direct |
16,824
-17.03%
|
$269,184
$16.49 P/Share
|
|
Sep 15
2021
|
Aranthan Jones Ii Chief Corp. Affairs Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,119
+5.92%
|
$133,309
$11.8 P/Share
|
|
Sep 09
2021
|
Stephen Ray Mitchell |
SELL
Open market or private sale
|
Direct |
19,109
-67.47%
|
$305,744
$16.74 P/Share
|
|
Sep 09
2021
|
Stephen Ray Mitchell |
BUY
Exercise of conversion of derivative security
|
Direct |
19,109
+29.96%
|
$210,199
$11.64 P/Share
|
|
Aug 20
2021
|
Joakim Wijkstrom SVP, Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
3,650
-4.67%
|
$54,750
$15.39 P/Share
|
|
Aug 16
2021
|
Timothy Williams SVP & General Counsel |
SELL
Open market or private sale
|
Direct |
3,715
-4.27%
|
$59,440
$16.15 P/Share
|
|
Jul 28
2021
|
Kevin Patrick Moran SVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
2,130
-2.1%
|
$40,470
$19.24 P/Share
|
|
Jul 26
2021
|
Aranthan Jones Ii Chief Corp. Affairs Officer |
SELL
Open market or private sale
|
Direct |
7,250
-7.72%
|
$137,750
$19.69 P/Share
|